We are live on ! Find out more
CMND icon

Clearmind Medicine
CMND

6 hedge funds and large institutions have $5.51M invested in Clearmind Medicine in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

20% more funds holding

Funds holding: 5 → 6 (+1)

2.11% more ownership

Funds ownership: 11.71% → 13.82% (+2.1%)

1% more capital invested

Capital invested by funds: $5.45M → $5.51M (+$60K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$12.3K
2
GAM
Gotham Asset Management
New York
+$3.08K
3
JP Morgan Chase
JP Morgan Chase
New York
+$3.08K

Top Sellers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
-$15.4K
2
TSS
Two Sigma Securities
New York
-$14.4K

CMND Hedge Fund Activity: Q2 2025 in Review

6 of the 7,617 institutional investors tracked by Wall St. Rank reported a position in Clearmind Medicine (CMND) for Q2 2025, worth a combined $5.51M — up 1.1% from $5.45M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CMND positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was XTX Topco, opening a new position worth an estimated $12.3K. The largest seller was AdvisorShares Investments, cutting an estimated $15.4K.

  • 6 institutional investors held Clearmind Medicine (CMND) as of Q2 2025, up from 5 in Q1 2025.
  • Funds reported $5.51M of Clearmind Medicine stock for Q2 2025, up 1.1% quarter-over-quarter.
  • 2 funds opened new Clearmind Medicine positions in Q2 2025 and 1 closed out, a net change of +1 holder.
  • The largest Clearmind Medicine buyer in Q2 2025 was XTX Topco, an estimated $12.3K added.
  • The largest Clearmind Medicine seller in Q2 2025 was AdvisorShares Investments, an estimated $15.4K sold.

Based on aggregated 13F filings for Q2 2025.